Preprint Article Version 2 Preserved in Portico This version is not peer-reviewed

Tissue-Engineered Anterior Segment Eye Cultures Maintain Intraocular Pressure

Version 1 : Received: 8 July 2019 / Approved: 10 July 2019 / Online: 10 July 2019 (09:53:49 CEST)
Version 2 : Received: 27 April 2020 / Approved: 28 April 2020 / Online: 28 April 2020 (10:42:13 CEST)
Version 3 : Received: 7 December 2020 / Approved: 8 December 2020 / Online: 8 December 2020 (10:09:17 CET)

How to cite: Waxman, S.; Wang, C.; Dang, Y.; Loewen, R.; Loewen, N.A. Tissue-Engineered Anterior Segment Eye Cultures Maintain Intraocular Pressure. Preprints 2019, 2019070142. https://doi.org/10.20944/preprints201907.0142.v2 Waxman, S.; Wang, C.; Dang, Y.; Loewen, R.; Loewen, N.A. Tissue-Engineered Anterior Segment Eye Cultures Maintain Intraocular Pressure. Preprints 2019, 2019070142. https://doi.org/10.20944/preprints201907.0142.v2

Abstract

Glaucoma is a blinding disease largely caused by increased resistance to drainage of fluid from the eye’s anterior chamber, resulting in elevated intraocular pressure (IOP). A major site of fluid outflow regulation and pathology is the trabecular meshwork (TM) at the entrance of the eye’s drainage system. We aimed to characterize the structural and functional properties of a newly developed tissue-engineered anterior segment eye culture model. We hypothesized that repopulation of a decellularized TM with non-native TM cells could restore aspects of normal TM. The decellularization protocol removed all cells and debris while preserving the ECM. Seeded cells localized to the TM region and progressively infiltrated the meshwork ECM. Cells reached a distribution comparable to control TM after four days of perfusion culture. After a perfusion rate increase challenge, tissue-engineered cultures reestablished normal IOPs (reseeded = 13.7±0.4 mmHg, decellularized = 35.2±2.2 mmHg, p < 0.0001). eGFP expressing CrFK control cells caused a high and unstable IOP (27.0±6.2 mmHg). In conclusion, we describe a readily available, storable, and biocompatible scaffold for anterior segment perfusion culture of non-native cells. Tissue-engineered organs demonstrated similarities to native tissues and may reduce the need for scarce donor globes in outflow research.

Keywords

glaucoma; tissue engineering; trabecular meshwork; outflow facility

Subject

Medicine and Pharmacology, Ophthalmology

Comments (1)

Comment 1
Received: 28 April 2020
Commenter: Susannah Waxman
Commenter's Conflict of Interests: Author
Comment: This is the most recent version of the revised manuscript submitted for peer review.  
+ Respond to this comment

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 1
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.